Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Pepsi slashed at JPMorgan, ‘more attractive options elsewhere': 4 big analyst cuts

Published 12/19/2023, 07:59 AM
Updated 12/19/2023, 07:59 AM
© Reuters.

Investing.com — Here is your Pro Recap of the biggest analyst cuts you may have missed today: downgrades at PepsiCo, Masonite International, Plug Power , and Disc Medicine.

InvestingPro subscribers got this news first. Never miss another market-moving headline.

PepsiCo cut to Neutral at JPMorgan

JPMorgan downgraded PepsiCo Inc (NASDAQ:PEP) to Neutral from Overweight and cut its price target to $176.00 from $185.00 in conjunction with its 2024 Year Ahead Outlook.

While acknowledging that there are no fundamental issues with Pepsico and expressing confidence in the company's ability to achieve its 2024 outlook (which includes a high-end of its long-term financial algorithm of 4-6% organic sales growth and high single-digit FX-neutral EPS growth), the analysts believe the potential for upward estimate revisions is diminishing.

The analysts see more promising opportunities in the Beverages sector with Overweight-rated companies like Coca-Cola (NYSE:KO) and Keurig Dr Pepper (NASDAQ:KDP), which are expected to exhibit higher quality top-line growth in 2024 and don't face the narrative challenges associated with GLP-1 concerns.

InvestingPro | Prevent Losses

Masonite International downgraded at Baird

Baird downgraded Masonite International (NYSE:DOOR) to Neutral from Outperform with a price target of $92.00 (from $106.00), as reported in real-time on InvestingPro.

The analysts explained that the downgrade is a response to Masonite's recent announcement of acquiring PGT Innovations (NYSE:PGTI) for $3 billion, which resulted in a nearly 16% drop in Masonite’s shares on Monday.

According to the analysts, this acquisition alters the previous investment thesis for Masonite, introducing a higher risk profile due to factors such as increased overall leverage, the possibility of a competing offer, and typical integration challenges. These risks, according to the analysts, are likely to need time to be properly digested, overwhelming the potential benefits of solid EPS growth expected by 2026/2027.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

We think the deal keeps shares rangebound in the near term. PGTI is a good asset, but we're not fully convinced it needs to be combined with DOOR under one roof.

Two more downgrades

Piper Sandler downgraded Plug Power (NASDAQ:PLUG) to Underweight from Neutral and cut its price target to $2.30 from $6.50. As a result, shares plunged more than 5% pre-market today.

Morgan Stanley downgraded Disc Medicine (NASDAQ:IRON) to Equalweight from Overweight with a price target of $65.00 (from $56.00).

Amid whipsaw markets and a slew of critical headlines, seize on the right timing to protect your profits: Always be the first to know with InvestingPro.

InvestingPro | Be The First To Know

Latest comments

hi
g kon
I heard Pepsi with bourbon is bad for you, so I stopped drinking Pepsi
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.